Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 8Terminated 7Recruiting 6Withdrawn 2Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Head & Neck 1

Conditions

Prostatic Neoplasms 220Urinary Bladder Neoplasms 54Carcinoma, Renal Cell 53Neoplasms 27Non-Muscle Invasive Bladder Neoplasms 26Kidney Neoplasms 25Breast Neoplasms 17Carcinoma, Transitional Cell 15Adenocarcinoma 15Melanoma 11Disease 11Neoplasm Metastasis 10Colorectal Neoplasms 10Uterine Cervical Neoplasms 9Endometrial Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Ovarian Neoplasms 7Lung Neoplasms 7Clear-cell metastatic renal cell carcinoma 7Triple Negative Breast Neoplasms 6Testicular Neoplasms 6Recurrence 6Urologic Neoplasms 5Urinary Incontinence 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pancreatic Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Hepatocellular 5

Interventions

toripalimab 1Mitomycin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma in Situ × Genitourinary × Clear all
NCT07480356 2026-03-18

ADVANCED-3

Protara Therapeutics

Phase 3 Not yet recruiting
284 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

NCT07189793 2025-09-24

OHAI-NMIBC-01

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Not yet recruiting
106 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡